Displaying drugs 1001 - 1025 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Fludarabine | 285.235 C10H12FN5O4 |  | A purine analog antimetabolite that inhibits DNA synthesis. | Purine Analogues |
| Oxamniquine | 279.3348 C14H21N3O3 |  | For treatment of Schistosomiasis caused by Schistosoma mansoni | Quinoline Derivatives and Related Substances |
| Trolamine salicylate | 287.312 C13H21NO6 |  | A medication used to relieve minor aches and pains of the muscles and joints. | Sunscreen Agents |
| Sodium camphorsulfonate | 254.28 C10H15NaO4S |  | Not Annotated | Not Annotated |
| Nifedipine | 346.3346 C17H18N2O6 |  | A dihydropyridine calcium channel blocker indicated for the management of several subtypes of angina pectoris, and hypertension. | Beta blocking agents and calcium channel blockers / Dihydropyridine Derivatives |
| Diacetyl benzoyl lathyrol | 522.638 C31H38O7 |  | Diacetyl benzoyl lathyrol is an active ingredient in whitening creams. It is also reported to be a skin conditioning agent. | Not Annotated |
| Lenacapavir | 968.28 C39H32ClF10N7O5S2 |  | A first-in-class capsid inhibitor being investigated for use in HIV-1 treatment. | Anti-HIV Agents / Antiinfectives for Systemic Use / Antiviral Agents / Antivirals for Systemic Use / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (moderate) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Direct Acting Antivirals / Heterocyclic Compounds, Fused-Ring / Human Immunodeficiency Virus 1 Capsid Inhibitor / P-glycoprotein substrates / Pyrazoles / UGT1A1 Substrates |
| Ixabepilone | 506.7 C27H42N2O5S |  | A microtubule inhibitor administered in combination with capecitabine or alone in the treatment of metastatic or locally advanced breast cancer that has shown inadequate response to taxanes and anthracyclines. | Microtubule Inhibitors / Tubulin Modulators |
| Hydrocortisone succinate | 462.539 C25H34O8 |  | A corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders. | Anti-Inflammatory Agents / Corticosteroids |
| Tigecycline | 585.6487 C29H39N5O8 |  | A glycylcycline antibiotic used to treat a number of susceptible bacterial infections. | Anti-Bacterial Agents / Protein Synthesis Inhibitors / Tetracyclines |
| Ketoprofen | 254.2806 C16H14O3 |  | An NSAID used to treat rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, dysmenorrhea, mild to moderate muscle pain, postoperative pain, and postpartum pain. | Antiinflammatory Preparations, Non-Steroids for Topical Use / Propionates |
| Lumiracoxib | 293.721 C15H13ClFNO2 |  | For the acute and chronic treatment of the signs and symptoms of osteoarthritis of the knee in adults. | COX-2 Inhibitors / Selective Cyclooxygenase 2 Inhibitors (NSAIDs) |
| Alclofenac | 226.66 C11H11ClO3 |  | Alclofenac is indicated in rheumatology, in particular for the treatment of rheumatoid arthritis, ankylosing spondylitis and, as an analgesic, in painful arthritic pathologies. | Acetic Acid Derivatives and Related Substances |
| Levomenthol | 156.2652 C10H20O |  | An organic compound used to treat mild to moderate muscle and joint pain. | Antipruritics / Cyclohexanols |
| Dexketoprofen | 254.2806 C16H14O3 |  | An NSAID that is the R(-)-enantiomer of racemic ketoprofen with analgesic and anti-inflammatory properties used for the treatment of mild to moderate pain. | Antiinflammatory Preparations, Non-Steroids for Topical Use / Propionates |
| Elexacaftor | 597.66 C26H34F3N7O4S |  | A small molecule CFTR corrector used in combination with tezacaftor and ivacaftor for the treatment of cystic fibrosis patients with one F508del-CFTR mutation. | Cystic Fibrosis Transmembrane Conductance Regulator Correctors / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A4 Substrates (strength unknown) / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Membrane Transport Modulators / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates |
| Silver sulfadiazine | 357.137 C10H9AgN4O2S |  | A topical sulfonamide antibiotic that acts on the bacterial cell wall and cell membrane; approved for the treatment of burns. | Sulfonamides |
| Naproxen | 230.2592 C14H14O3 |  | An NSAID used to treat rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and mild to moderate pain. | Antiinflammatory Preparations, Non-Steroids for Topical Use / Antiinflammatory Products for Vaginal Administration / Propionates |
| Carbimazole | 186.232 C7H10N2O2S |  | A drug used for the reduction of thyroid function. | Sulfur-Containing Imidazole Derivatives |
| Mazindol | 284.74 C16H13ClN2O |  | A sympathomimetic used to treat obesity in combination with lifestyle modifications. | Centrally Acting Antiobesity Products |
| Fluciclovine (18F) | 132.125 C5H8FNO2 |  | A radiolabelled L-leucine derivative used to image tumors, especially in the prostate. | Radioactive Diagnostic Agent |
| Pegulicianine | Not Annotated |  | An optical imaging agent used for fluorescence imaging to detect cancerous tissue within the resection cavity following removal of the primary specimen during lumpectomy surgery. | Contrast Media / Fluorescent Dyes |
| Clobazam | 300.74 C16H13ClN2O2 |  | A benzodiazepine used as adjunct treatment in seizures associated with Lennox-Gastaut syndrome. | Anticonvulsants / Benzodiazepines and benzodiazepine derivatives / GABA-A Receptor Agonists |
| Mirabegron | 396.506 C21H24N4O2S |  | A beta-3 adrenergic agonist used to treat overactive bladder and neurogenic detrusor overactivity. | Drugs for Urinary Frequency and Incontinence |
| Retapamulin | 517.763 C30H47NO4S |  | A topical antibiotic agent used for the treatment of impetigo caused by methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes. | Anti-Bacterial Agents / Pleuromutilin Antibacterial |
Displaying drugs 1001 - 1025 of 2785 in total